CTN study tests new drug for the first time in people living with HIV
The drug works against CMV, a common virus that may be a main cause of inflammation and health problems in people living with HIV
Learn MoreFebruary 2, 2022
Improving anal cancer screening among men living with HIV
Ahead of World Cancer Day, we spoke with Dr. Troy Grennan about anal cancer screening among gbMSM living with HIV, a population disproportionately affected by the condition
Learn More
Let’s Talk: Addressing mental health in the HIV community
In recognition of Bell Let’s Talk Day, we look at what steps can be taken to improve mental health and wellbeing among people affected by HIV
Learn More
ENGAGing men in HIV prevention and care
CTN 300: The Engage Study is investigating the use of PrEP among urban Canadian gay, bisexual, and other men who have sex with men
Learn More
Does the COVID-19 vaccine work for people living with HIV?
A new national study, called HIVCOV (CTN 328), will assess COVID-19 vaccine immune responses and effectiveness among people living with HIV
Learn More
Understanding the impacts of prenatal antiretroviral medications on children
A new CTN study investigates how exposure to HIV and antiretroviral drugs during pregnancy could have long-term effects for the millions of kids who were born to mothers living with HIV, but who did not acquire the virus themselves
Learn More
TEACHHing service providers how to best care for trans people
March 31 marks the International Transgender Day of Visibility, an annual event dedicated to celebrating...
Learn More
Seven ways the Community Advisory Committee strengthens HIV research
Here are the seven ways that the CTN works towards the meaningful involvement of people...
Learn More
Treating liver disease in people living with HIV
The CTNPT 024 team investigated whether vitamin E could be a treatment option for NASH, a type of liver disease that is more common among people living with HIV
Learn More